Loading organizations...
Loading organizations...

98point6: Healthcare technology company licensing AI-powered text-based digital primary care software to health systems and healthcare companies.
Based in Seattle, Washington, 98point6 is a healthcare technology company that develops and licenses an artificial intelligence-powered, text-based virtual care platform for health systems and providers. The company originally operated as a direct-to-consumer and employer-sponsored telehealth provider before pivoting to a business-to-business software licensing model in 2023. As part of this strategic shift, the organization sold its clinical care delivery business and affiliated medical group to Transcarent in a transaction valued at up to $100 million. Prior to the sale, the platform served approximately four million patients through more than 240 commercial partnerships, including contracts with major employers like Boeing and Chipotle. The enterprise has raised $297 million in total venture funding from backers such as Goldman Sachs and L Catterton. 98point6 was founded in 2015 by Robbie Cape, Gordon Cohen, and Jeff Greenstein.
98point6 has raised $292.2M across 7 funding rounds.
98point6 has raised $292.2M in total across 7 funding rounds.
98point6 has raised $292.2M in total across 7 funding rounds.
98point6's investors include Activant Capital, L Catterton, Transcarent, Michael Farello, Goldman Sachs, David Viniar, Jim Sinegal, Laurence D. Fink, Nader Naini, Jo N..
98point6 has raised $292.2M across 7 funding rounds. Most recently, it raised $30.7M Debt in April 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 18, 2023 | $30.7M Debt | Activant Capital, L Catterton | Transcarent |
| Sep 3, 2022 | $20.0M Other Equity | Activant Capital, L Catterton | |
| Oct 15, 2020 | $118.0M Series E | Activant Capital, Michael Farello | Goldman Sachs |
| Apr 6, 2020 | $43.0M Series D | David Viniar, Jim Sinegal, Laurence D. Fink, Nader Naini, Goldman Sachs | |
| Oct 31, 2018 | $50.0M Series C | Jo N. | |
| Sep 19, 2017 | $19.5M Series B | ||
| Aug 2, 2016 | $11.0M Other Equity |